Workflow
Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?
DGXQuest Diagnostics(DGX) ZACKS·2025-04-15 15:06

Core Viewpoint - The market anticipates Quest Diagnostics (DGX) will report a year-over-year increase in earnings driven by higher revenues for the quarter ended March 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Quest Diagnostics is expected to post quarterly earnings of 2.16pershare,reflectingayearoveryearincreaseof+5.92.16 per share, reflecting a year-over-year increase of +5.9% [3]. - Revenues are projected to reach 2.62 billion, representing a 10.6% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.13% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Quest Diagnostics is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -2.11%, suggesting a bearish outlook from analysts [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of actual earnings deviating from consensus estimates, with positive readings being more reliable [6][7]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of delivering a positive surprise [8]. Historical Performance - In the last reported quarter, Quest Diagnostics exceeded the expected earnings of 2.19persharebydelivering2.19 per share by delivering 2.23, resulting in a surprise of +1.83% [12]. - The company has beaten consensus EPS estimates in all of the last four quarters [13]. Conclusion - Despite the potential for an earnings beat, Quest Diagnostics does not currently appear to be a strong candidate for exceeding earnings expectations, and investors should consider other influencing factors before making investment decisions [16].